Epidemiology of anthracycline cardiotoxicity in children and adults.
about
Cardiotoxicity in childhood cancer survivors: strategies for prevention and managementPharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donorsCardiac effects of anticancer therapy in the elderlyCardiac imaging approaches to evaluate drug-induced myocardial dysfunctionEarly detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography.Effect of dexrazoxane and amifostine on the vertebral bone quality of Doxorubicin treated male ratsPregnancy in a patient with cancer and heart failure: challenges and complexities.Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice.Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome.Cardiac function in long-term survivors of childhood lymphoma.Cardiovascular effects in childhood cancer survivors treated with anthracyclines.Anthracycline cardiotoxicity: prevalence, pathogenesis and treatmentPhysical therapy and chiropractic use among childhood cancer survivors with chronic disease: impact on health-related quality of life.Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndrome.Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation.Anthracycline-Related Cardiotoxicity in Patients with Acute Myeloid Leukemia and Down Syndrome: A Literature ReviewRole of DNA Methylation on the Expression of the Anthracycline Metabolizing Enzyme AKR7A2 in Human Heart.Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity.Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network.Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin.Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems databaseKrüppel-like Factor 13 Is a Major Mediator of Glucocorticoid Receptor Signaling in Cardiomyocytes and Protects These Cells from DNA Damage and Death.Identification of the promoter of human carbonyl reductase 3 (CBR3) and impact of common promoter polymorphisms on hepatic CBR3 mRNA expression.Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors.Tirapazamine-doxorubicin interaction referring to heart oxidative stress and Ca²⁺ balance protein levels.Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine.The redox imbalance and the reduction of contractile protein content in rat hearts administered with L-thyroxine and Doxorubicin.Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion.Population pharmacokinetics of liposomal daunorubicin in children.Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Platform for Testing For Drug Cardiotoxicity.Dexrazoxane Significantly Reduces Anthracycline-induced Cardiotoxicity in Pediatric Solid Tumor Patients: A Systematic Review.Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy.
P2860
Q24628695-A01EDCE1-745C-4239-82FB-82A2D08E2BBEQ24646186-DC6214BB-372E-4C03-92E7-00E225431590Q26863244-F99216FC-812C-4E08-B25B-27BB63DDDB3EQ30446453-39AB5793-2A6C-4CD5-A9F2-BE74F61A6402Q30491590-ADFF54D8-F390-4C55-A262-1FFD6268141CQ33455575-FB88B2AC-432B-4F05-8A8B-ED44CC288881Q33885550-EE8B6148-D13F-45A2-AF73-F321724EB871Q34145974-644FF26B-87AB-4815-887F-24B1A67E3F49Q34359464-BA636D83-0A5A-446D-8AF5-CD641238CC2CQ34557579-1F7B08F0-AAFD-4981-A0DF-FC3E6E003952Q34572109-48FD96BF-0892-47C5-851C-7DF934F53667Q34639876-159E5950-2547-401B-9F0A-4D2C86CDEA9CQ34706978-75F7DD3B-AB86-4941-9252-649E886C152BQ35044480-4A3A5CD1-67B3-43EC-ABC6-E5B65FE94FF5Q35076156-1E9C5210-BC6A-48FF-AABC-FD612F365AE8Q35086334-1135A3D5-3988-4B44-8777-7F519875FCB1Q35184667-D61E1FAD-8FA4-4A1E-AD45-06D144077D30Q35490056-26035746-E0FA-4630-8BE0-E3BB93449CB3Q35604039-80BA8039-0BE0-483F-AE17-85BF72630BCBQ35888110-248003A5-CDC0-4C95-ACC5-9BE55F16A96CQ36276059-E4C05389-6EA8-43C2-BDBE-DCD93299B5FCQ36467387-9666CAFD-F66A-43CE-819A-8CD5359BA9D1Q36589035-77F9F8A9-D56F-4041-802C-CC1A973A4261Q36625957-D3223A1B-738E-4551-903B-BFE0A79F6DDBQ37350809-121A1A61-7D32-4775-9324-B8A2D7BC25BBQ37355919-51592E89-2D02-4746-B860-5389E09F9CA8Q37569911-D0178E9F-0EF6-4D8F-B3CF-A3605F857C22Q39566448-E6D8968C-9372-4E93-864F-F4CE6B91BEB8Q39826773-B27A72DE-8B21-43DC-BCBE-01F7CB3D0234Q40065987-89E6D15D-C48A-4AF6-B535-31335AC13C3DQ41991319-86AACCE2-6418-49E7-9531-CF20E95530ADQ42130469-C75C80DD-AED5-4F81-8AD5-D2E55285BCFAQ42560693-00CC883A-BCFE-4D36-8FDA-5089E7BDD5EDQ42706690-398F5E00-131D-4821-9DEA-B6B238C7E97EQ42760004-1921748F-8513-416E-95CE-C023F1692C40Q46801702-93AB7A5C-90E2-40A4-9354-AE1965AAF63AQ50047368-21BD5F0C-EA7A-4C78-9109-5FDFAF6E25F1Q54976923-24393ED3-E0C3-4588-BBCF-23FB929864F7
P2860
Epidemiology of anthracycline cardiotoxicity in children and adults.
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Epidemiology of anthracycline cardiotoxicity in children and adults.
@ast
Epidemiology of anthracycline cardiotoxicity in children and adults.
@en
Epidemiology of anthracycline cardiotoxicity in children and adults.
@nl
type
label
Epidemiology of anthracycline cardiotoxicity in children and adults.
@ast
Epidemiology of anthracycline cardiotoxicity in children and adults.
@en
Epidemiology of anthracycline cardiotoxicity in children and adults.
@nl
prefLabel
Epidemiology of anthracycline cardiotoxicity in children and adults.
@ast
Epidemiology of anthracycline cardiotoxicity in children and adults.
@en
Epidemiology of anthracycline cardiotoxicity in children and adults.
@nl
P1433
P1476
Epidemiology of anthracycline cardiotoxicity in children and adults
@en
P2093
Grenier MA
Lipshultz SE
P433
4 Suppl 10
P577
1998-08-01T00:00:00Z